Related Experiment Video
Updated: May 27, 2026
07:52
A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Relationship between hyperuricemia and chronic kidney disease.
1Department of Internal Medicine, Division of Kidney and Hypertension, Jikei University School of Medicine, Nishi-Shinbashi Minato-ku, Tokyo, Japan.
Nucleosides, Nucleotides & Nucleic Acids
|December 3, 2011
Summary
Hyperuricemia, linked to kidney disease, contributes to hypertension and renal damage. Treating high uric acid levels with allopurinol can lower blood pressure and slow kidney disease progression.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Metabolic Disorders
Background:
- Hyperuricemia is common in deteriorating renal function, but its role in disease progression was unclear.
- Serum uric acid levels correlate with hypertension onset and severity.
- Hyperuricemia is a known risk factor for renal insufficiency and a poor prognostic factor in IgA nephropathy.
Purpose of the Study:
- To investigate the role of hyperuricemia in the progression of renal disease.
- To explore the association between hyperuricemia, hypertension, and chronic kidney disease (CKD).
- To evaluate the impact of hyperuricemia treatment on blood pressure and renal damage.
Main Methods:
- Analysis of cross-sectional and longitudinal clinical studies.
- Review of intervention studies involving allopurinol treatment in CKD patients.
- Examination of the influence of renin-angiotensin system inhibitors (ACEI/ARB) in hyperuricemia-related renal damage.
Main Results:
- Hyperuricemia is associated with hypertension and its onset.
- Allopurinol treatment in CKD patients lowered blood pressure and inhibited renal damage progression.
- Cessation of allopurinol led to increased blood pressure and renal damage, particularly in patients not on ACEI or ARB.
Conclusions:
- Hyperuricemia plays a significant role in the progression of renal disease and hypertension.
- Allopurinol treatment is effective in managing blood pressure and slowing CKD progression.
- The renin-angiotensin system is implicated in the development of hypertension and renal damage associated with hyperuricemia.
Related Concept Videos
01:25Chronic Kidney Disease I: Introduction
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
01:24Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
01:17Factors Affecting Renal Clearance: Renal Impairment
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...